Establishment of Drug Registration Applicant Compliance Management Organizations in the United States and Its Enlightenment to China
- VernacularTitle:美国药品注册申请人合规管理机构设置情况及对我国的启示
- Author:
Yi YAO
1
;
Yanjiao ZHAO
1
;
Xin FAN
1
;
Yongfa CHEN
1
Author Information
1. School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing 211198,China
- Publication Type:Journal Article
- Keywords:
Compliance management organization;
Drug
- From:
China Pharmacy
2020;31(12):1414-1418
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for further improving the establishment of drug registration applicant compliance management organizations in China. METHODS :Through introducing and analyzing the establishment ,responsibility configuration and operation mechanism of drug registration applicant compliance management organizations in the United States ,the suggestions were put forward for improving the establishment of drug registration applicant compliance management institutions in China. RESULTS & CONCLUSIONS :There were two levels of compliance management organizations for drug registration applicant in the United States ;at Office of the Commissioner of FDA level ,the Compliance Policy Council was responsible for ensuring consistency in the implementation of all compliance policies in the FDA regulated area ;at the level of Center for Drug Evalution and Research (CDER)and Office of Regulatory Affairs (ORA),the compliance management function was mainly undertaken by Office of New Drugs (OND),Office of Generic Drugs (OGD),Office of Compliance (OC) and Office of Communication (OCOMM)under CDER ,as well as Office of Policy and Risk Management (OPRM),OC,Office of Bioresearch Monitoring Operations(OBIMO)and Office of Pharmaceuticl Quality Operations (OPQO)under ORA ,which were responsible for developing compliance documents and procedures ,carrying out compliance education ,compliance guidance ,compliance inspection and punishment for violations. Before submission stage of drug registration application ,the compliance education function of OC and the compliance guidance function of OND/OGD played an important role ;in the application submission stage ,OND/OGD was responsible for the compliance review of application materials ;in the stage of reviewing the application materials ,OND/OGD and OC of CDER ensured drug compliance through collaboration with OC ,OBIMO and OPQO of ORA. The establishment of drug registration compliance management institutions in China was still in the preliminary exploration stage. It is suggested that China can learn from the relevant experience of the United States ,establish a multi-level or ganization structure ,set up an independent compliance education department , and strengthen thecooperation between evaluation department and compliance inspection department ,and to improve the level of compliance management of drug registration applicants in China.